Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Moose, As I said before, the more they delay the BO, the costlier it gets for them. Unless the p2 results are bogus, the longs are in for a big payday. The p2 results data has been validated and confirmed by the medical world as a resounding success. I can't see healthier p3 LN patients not responding equally or better than P2 patients since both trials have the same design protocol. We are in good shape but we definitely will hear whining and moaning from some retail investors who watch the pps on a daily basis.